Liu J, Huang W, Hu J, Hong N, Rhee Y, Li Q
JACC Asia. 2025; 4(12):972-984.
PMID: 39802987
PMC: 11712017.
DOI: 10.1016/j.jacasi.2024.09.010.
Hu Z, Chen X, Cheng Y, Zhong P, Li Q, Zhao Y
J Clin Hypertens (Greenwich). 2024; 26(9):1082-1089.
PMID: 39037171
PMC: 11488322.
DOI: 10.1111/jch.14874.
Chen J, Huang K, Lin Y, Chueh J, Wang H, Wu V
J Clin Endocrinol Metab. 2023; 109(3):e965-e974.
PMID: 38051943
PMC: 10876388.
DOI: 10.1210/clinem/dgad709.
Chen P, Chang D, Liu K, Liao W, Wang W, Chang C
Sci Rep. 2022; 12(1):8892.
PMID: 35614110
PMC: 9132956.
DOI: 10.1038/s41598-022-12835-9.
Wu Y, Chen C, Chen P, Kuo C, Hung Y, Peng K
BMC Bioinformatics. 2022; 22(Suppl 10):613.
PMID: 35012455
PMC: 8750845.
DOI: 10.1186/s12859-022-04561-w.
Characteristics of a Novel K416_F418delinsN Mutation in a Classical Aldosterone-Producing Adenoma.
Liao H, Peng K, Wu V, Lin Y, Lin S, Lin W
Cancers (Basel). 2021; 13(18).
PMID: 34572956
PMC: 8472399.
DOI: 10.3390/cancers13184729.
Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.
Chen K, Lee B, Chen P, Liu K, Lin K, Chang C
Front Endocrinol (Lausanne). 2021; 12:647184.
PMID: 34335463
PMC: 8323492.
DOI: 10.3389/fendo.2021.647184.
Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma.
Er L, Lin M, Tsai Y, Hsiao J, Yang C, Chang C
BMJ Open Diabetes Res Care. 2020; 8(1).
PMID: 32713841
PMC: 7383952.
DOI: 10.1136/bmjdrc-2019-001153.
Plasma Aldosterone Concentration as a Determinant for Statin Use among Middle-Aged Hypertensive Patients for Atherosclerotic Cardiovascular Disease.
Lin J, Lin Y, Wang W, Lin Y, Jeff Chueh S, Wu V
J Clin Med. 2018; 7(11).
PMID: 30355992
PMC: 6262476.
DOI: 10.3390/jcm7110382.
Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications.
Chang C, Yang S, Tsai Y, Kuo S, Cherng S, Lu C
Tzu Chi Med J. 2018; 30(3):169-175.
PMID: 30069126
PMC: 6047325.
DOI: 10.4103/tcmj.tcmj_106_17.
The relationship among cardiac structure, dietary salt and aldosterone in patients with primary aldosteronism.
Hung C, Wu X, Chen C, Chen Y, Wu V, Liao C
Oncotarget. 2017; 8(42):73187-73197.
PMID: 29069862
PMC: 5641205.
DOI: 10.18632/oncotarget.17505.
Identifying unilateral disease in Chinese patients with primary aldosteronism by using a modified prediction score.
Zhang Y, Niu W, Zheng F, Zhang H, Zhou W, Shen Z
J Hypertens. 2017; 35(12):2486-2492.
PMID: 28708774
PMC: 5673302.
DOI: 10.1097/HJH.0000000000001488.
The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes.
Wu V, Wang S, Jeff Chueh S, Yang S, Huang K, Lin Y
Sci Rep. 2017; 7:39121.
PMID: 28102204
PMC: 5244399.
DOI: 10.1038/srep39121.
Non-stimulated adrenal venous sampling using Dyna computed tomography in patients with primary aldosteronism.
Chang C, Lee B, Liu K, Chang Y, Wu V, Huang K
Sci Rep. 2016; 6:37143.
PMID: 27876824
PMC: 5120298.
DOI: 10.1038/srep37143.
Evaluation of right adrenal vein anatomy by Dyna computed tomography in patients with primary aldosteronism.
Lee B, Chang C, Liu K, Chang Y, Wu V, Huang K
Sci Rep. 2016; 6:28305.
PMID: 27334209
PMC: 4917856.
DOI: 10.1038/srep28305.
Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients.
Liao C, Lin L, Hung C, Lin Y, Chang Y, Wang S
Sci Rep. 2016; 6:20862.
PMID: 26883298
PMC: 4756682.
DOI: 10.1038/srep20862.
Reversible heart rhythm complexity impairment in patients with primary aldosteronism.
Lin Y, Wu V, Lo M, Wu X, Hung C, Wu K
Sci Rep. 2015; 5:11249.
PMID: 26282603
PMC: 4539539.
DOI: 10.1038/srep11249.
Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population.
Wu V, Huang K, Peng K, Tsai Y, Wu C, Wang S
Sci Rep. 2015; 5:11396.
PMID: 26066391
PMC: 4464349.
DOI: 10.1038/srep11396.
Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans.
Lin Y, Chou C, Wu X, Chang Y, Hung C, Chen Y
PLoS One. 2014; 9(9):e95254.
PMID: 25180794
PMC: 4152338.
DOI: 10.1371/journal.pone.0095254.
The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.
Kuo C, Balakrishnan P, Hsein Y, Wu V, Jeff Chueh S, Chen Y
J Renin Angiotensin Aldosterone Syst. 2014; 16(3):587-98.
PMID: 25031295
PMC: 4297265.
DOI: 10.1177/1470320313498632.